- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 23 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
NAG.14: 2 residues within 4Å:- Chain A: E.268, N.269
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: N.696, G.1118
Ligand excluded by PLIPNAG.16: 4 residues within 4Å:- Chain A: F.329, N.330, S.358, F.361
Ligand excluded by PLIPNAG.17: 4 residues within 4Å:- Chain A: C.2, V.3, N.4, N.124
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.318, Q.567
Ligand excluded by PLIPNAG.19: 3 residues within 4Å:- Chain A: A.693, S.698, N.1061
Ligand excluded by PLIPNAG.20: 1 residues within 4Å:- Chain D: N.318
Ligand excluded by PLIPNAG.21: 4 residues within 4Å:- Chain D: F.325, G.326, F.329, N.330
Ligand excluded by PLIPNAG.22: 7 residues within 4Å:- Chain D: F.73, N.183, G.219, I.220, N.221, I.222, T.223
Ligand excluded by PLIPNAG.23: 1 residues within 4Å:- Chain D: N.603
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain D: N.696, G.1118
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain D: A.693, E.1059, N.1061
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain D: C.2, V.3, N.4, N.124
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain D: N.267, N.269
- Chain E: K.545
Ligand excluded by PLIPNAG.28: 3 residues within 4Å:- Chain E: N.109, T.111, V.114
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain E: N.267, E.268, N.269
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain E: N.603, T.605
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain E: H.642, N.644
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain D: D.783
- Chain E: N.696, I.1117, G.1118
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain E: A.693, N.1061
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain E: T.95, N.221
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain E: C.2, V.3, N.4, N.124
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain E: N.318, Q.567
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thijssen, V. et al., A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein. Proc.Natl.Acad.Sci.USA (2023)
- Release Date
- 2023-06-28
- Peptides
- Spike glycoprotein,Fibritin: ADE
Macrocyclic peptide S1B3inL1: BCF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BD
AE
CB
EC
DF
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-mer
- Ligands
- 13 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 23 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Thijssen, V. et al., A broad-spectrum macrocyclic peptide inhibitor of the SARS-CoV-2 spike protein. Proc.Natl.Acad.Sci.USA (2023)
- Release Date
- 2023-06-28
- Peptides
- Spike glycoprotein,Fibritin: ADE
Macrocyclic peptide S1B3inL1: BCF - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BD
AE
CB
EC
DF
F